Medical Dosimetry
Volume 35, Issue 3 , Pages 214-219 , Autumn 2010

Helical Tomotherapy and Larynx Sparing in Advanced Oropharyngeal Carcinoma: A Dosimetric Study

Preliminary data was presented as a poster at the American Society for Therapeutic Radiology and Oncology Annual Meeting in Boston, Massachusetts, September 21, 2008.

Received 26 February 2009 ,Accepted 8 June 2009.

References 

  1. Fu KK, Pajak TF, Trotti A, et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int. J. Radiat. Oncol. Biol. Phys. 2000;48:7–16
  2. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J. Clin. Oncol. 2003;21:92–98
  3. Denis F, Garaud P, Bardet E, et al. Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: Comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems. Int. J. Radiat. Oncol. Biol. Phys. 2003;55:93–98
  4. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338:1798–1804
  5. Jeremic B, Shibamoto Y, Milicic B, et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial. J. Clin. Oncol. 2000;18:1458–1464
  6. de Arruda FF, Puri DR, Zhung J, et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience. Int. J. Radiat. Oncol. Biol. Phys. 2006;64:363–373
  7. Yao M, Dornfeld KJ, Buatti JM, et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma—The University of Iowa experience. Int. J. Radiat. Oncol. Biol. Phys. 2005;63:410–421
  8. Garden AS, Morrison WH, Wong PF, et al. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2007;67:438–444
  9. Mendenhall WM, Morris CG, Amdur RJ, et al. Definitive radiotherapy for tonsillar squamous cell carcinoma. Am. J. Clin. Oncol. 2006;29:290–297
  10. Lee NY, de Arruda FF, Puri DR, et al. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2006;66:966–974
  11. Huang K, Xia P, Chuang C, et al. Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: The University of California-San Francisco experience. Cancer. 2008;113:497–507
  12. Lin A, Kim HM, Terrell JE, et al. Quality of life after parotid-sparing IMRT for head-and-neck cancer: A prospective longitudinal study. Int. J. Radiat. Oncol. Biol. Phys. 2003;57:61–70
  13. Kam MK, Chau RM, Suen J, et al. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: Dosimetric advantage over conventional plans and feasibility of dose escalation. Int. J. Radiat. Oncol. Biol. Phys. 2003;56:145–157
  14. Ben-David MA, Diamante M, Radawski JD, et al. Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: Likely contributions of both dental care and improved dose distributions. Int. J. Radiat. Oncol. Biol. Phys. 2007;68:396–402
  15. Amdur RJ, Li JG, Liu C, et al. Unnecessary laryngeal irradiation in the IMRT era. Head. Neck. 2004;26:257–263
  16. Lee N, Mechalakos J, Puri DR, et al. Choosing an intensity-modulated radiation therapy technique in the treatment of head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2007;68:1299–1309
  17. Dabaja B, Salehpour MR, Rosen I, et al. Intensity-modulated radiation therapy (IMRT) of cancers of the head and neck: Comparison of split-field and whole-field techniques. Int. J. Radiat. Oncol. Biol. Phys. 2005;63:1000–1005
  18. Fung K, Yoo J, Leeper HA, et al. Vocal function following radiation for non-laryngeal versus laryngeal tumors of the head and neck. Laryngoscope. 2001;111:1920–1924
  19. Morton RP. Laryngeal cancer: Quality of life and cost-effectiveness. Head. Neck. 1997;19:243–250
  20. Stoeckli SJ. Quality of life after treatment for early glottic cancer. Eur. Arch. Otorhinolaryngol. 2001;258:96–99
  21. Fininzia C, Bergman B. Health-related quality of life in patients with laryngeal cancer: A post-treatment comparison of different modes of communication. Laryngoscope. 2001;111:918–923
  22. Krayenbuehl J, Davis JB, Ciernik IF. Dynamic intensity-modulated non-coplanar arc radiotherapy (INCA) for head and neck cancer. Radiother. Oncol. 2006;81:151–157
  23. Webster GJ, Rowbottom CG, Ho KF, et al. Evaluation of larynx-sparing techniques with IMRT when treating the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 2008;72:617–622
  24. Sheng K, Molloy JA, Read PW. Intensity-modulated radiation therapy (IMRT) dosimetry of the head and neck: A comparison of treatment plans using linear accelerator-based IMRT and helical tomotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2006;65:917–923
  25. van Vulpen M, Field C, Raaijmakers CP, et al. Comparing step-and-shoot IMRT with dynamic helical tomotherapy IMRT plans for head-and-neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 2005;62:1535–1539
  26. Fiorino C, Dell'Oca I, Pierelli A, et al. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy. Radiother. Oncol. 2006;78:276–282
  27. Wu Q, Mohan R, Niemierko A, et al. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int. J. Radiat. Oncol. Biol. Phys. 2002;52:224–235
  28. Niemierko A. Reporting, and analyzing dose distributions: A concept of equivalent uniform dose. Med. Phys. 1997;24:103–110
  29. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic radiation. Int. J. Radiat. Oncol. Biol. Phys. 1991;21:109–122
  30. Roh JL, Kim AY, Cho MJ. Xerostomia following radiotherapy of the head and neck affects vocal function. J. Clin. Oncol. 2005;23:3016–3023
  31. Dornfeld K, Hopkins S, Simmons J, et al. Posttreatment FDG-PET uptake in the supraglottic and glottic larynx correlates with decreased quality of life after chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2008;71:386–392
  32. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT?. Int. J. Radiat. Oncol. Biol. Phys. 2004;60:1425–1439
  33. Dornfeld K, Simmons JR, Karnell L, et al. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of lifey. Int. J. Radiat. Oncol. Biol. Phys. 2007;68:750–757

 Dr. Julius Turian and Dr. Joy Coleman have received research support from Tomotherapy® for prostate cancer research. Funding from Tomotherapy® did not support this study.

PII: S0958-3947(09)00054-5

doi: 10.1016/j.meddos.2009.06.002

Medical Dosimetry
Volume 35, Issue 3 , Pages 214-219 , Autumn 2010

Article Tools

* Image Usage & Resolution